Doxorubicin and paclitaxel loaded microbubbles for ultrasound triggered drug delivery.
about
Nanoparticle delivery enhancement with acoustically activated microbubbles.The role of acoustofluidics in targeted drug deliveryA review of low-intensity ultrasound for cancer therapy.Low Intensity Ultrasound Mediated Liposomal Doxorubicin Delivery Using Polymer Microbubbles.Nanoparticle Loaded Polymeric Microbubbles as Contrast Agents for Multimodal ImagingHematoPorphyrin Monomethyl Ether polymer contrast agent for ultrasound/photoacoustic dual-modality imaging-guided synergistic high intensity focused ultrasound (HIFU) therapy.Use of Theranostic Strategies in Myocardial Cavitation-Enabled TherapypH-triggered echogenicity and contents release from liposomes.Sonochemotherapy: from bench to bedsideUltrasound-mediated destruction of LHRHa-targeted and paclitaxel-loaded lipid microbubbles induces proliferation inhibition and apoptosis in ovarian cancer cellsCurrent status and prospects for microbubbles in ultrasound theranostics.Recent advances in molecular, multimodal and theranostic ultrasound imaging.In vitro gene delivery with ultrasound-triggered polymer microbubbles.Lung surfactant microbubbles increase lipophilic drug payload for ultrasound-targeted delivery.Scaled-Up Production of Monodisperse, Dual Layer Microbubbles Using Multi-Array Microfluidic Module for Medical Imaging and Drug DeliveryPlasmonic nanobubbles rapidly detect and destroy drug-resistant tumorsPreparation and characterization of magnetic alginate-chitosan hydrogel beads loaded matrine.Design of Albumin-Coated Microbubbles Loaded With Polylactide Nanoparticles.Magnetic targeting and ultrasound mediated drug delivery: benefits, limitations and combination.A novel technology: microfluidic devices for microbubble ultrasound contrast agent generation.In Vitro and In Vivo Evaluation of Targeted Sunitinib-Loaded Polymer Microbubbles Against Proliferation of Renal Cell Carcinoma.The progressive role of acoustic cavitation for non-invasive therapies, contrast imaging and blood-tumor permeability enhancement.A pH-sensitive binary drug delivery system based on poly(caprolactone)-heparin conjugates.The antitumor effect of a new docetaxel-loaded microbubble combined with low-frequency ultrasound in vitro: preparation and parameter analysis.Cellular signal transduction can be induced by TRAIL conjugated to microcapsules.In vivo targeted delivery of large payloads with an ultrasound clinical scanner.PBCA-based polymeric microbubbles for molecular imaging and drug deliveryTargeted delivery of CuS nanoparticles through ultrasound image-guided microbubble destruction for efficient photothermal therapy.Shell effects on acoustic performance of a drug-delivery system activated by ultrasound.Acoustic Characterization and Enhanced Ultrasound Imaging of Long-Circulating Lipid-Coated Microbubbles.Pro-apoptotic liposomes-nanobubble conjugate synergistic with paclitaxel: a platform for ultrasound responsive image-guided drug delivery.Physicochemical Characterization of the Shell Composition of PBCA-Based Polymeric Microbubbles.Magnetic nanobubbles with potential for targeted drug delivery and trimodal imaging in breast cancer: an in vitro study.Multimodal Molecular Imaging: Current Status and Future Directions.A Review of Thermo- and Ultrasound-Responsive Polymeric Systems for Delivery of Chemotherapeutic Agents
P2860
Q26866082-EB448B9C-2888-4B60-9177-704C6FDE0700Q27330355-49DEF56F-64BF-4F37-9005-D17E7B14BD4CQ28082093-BCFAF067-C1F3-4405-9A70-4E3E56BCB061Q30359572-5B92E863-012B-4ABE-B7CF-68C4E85DA938Q30370716-2DD2CAFA-4996-4319-BB4E-360D34861B50Q30375695-EA4B50BF-C62A-4A9A-AE97-233D26F36581Q30380567-2CC66D3D-C6B7-46C5-9B91-504A56930977Q30402045-1FC77A08-E825-41FC-A89E-A4B952E0D146Q30406257-9FA231F0-E324-4965-AC31-089FC9BE9322Q30421395-794F5B1D-FAE0-47C8-8A1C-CF0EF81CC579Q30435874-712A7571-AAD7-4582-A986-D75DF287FE23Q30436709-82E1BBA5-8338-43ED-BE05-E21698FCE8C5Q30437709-1E6A4721-36C3-4A36-A919-9D49B38627B1Q30453426-1561E4CD-0E11-45E2-BE62-BBE9C303BF02Q30454924-2A4253D0-4C43-4C5F-9708-A04F2A6CA733Q30461227-A7982456-FC25-421D-8BAE-7C3ABCE62CA9Q34076504-56941C18-E0C4-4F6E-9D46-5484CA59B673Q35954495-C1234F2D-5AE4-47FC-99A4-F21B04811D47Q38012538-72985914-1C8D-494C-A259-BBEEBF545735Q38789467-DD40C0D0-F220-4604-B55B-B2847E9A06D4Q38790666-F1A2577E-FDC2-4B56-A76E-2A2EDAE4E0B3Q38838201-D82D3AB8-BC35-4202-8F83-A0ADE7C4365DQ39171772-BCF1C4BC-FC74-4680-B8A2-3BC93C4C3E47Q39192903-8425FFC6-3580-43FF-8593-1165294E4157Q39357697-3303B014-975C-45CF-BD19-7D138226F78EQ40056859-D88B7B2B-0455-4CB0-B636-D519E6B7B8E2Q41131686-3ED7F52D-5CD2-45B0-AD41-B4B29384C7A3Q43940425-D384A8EC-E006-45D2-ADA1-05B0AFC2C48DQ47328097-54066CD6-7B3B-49EF-9F59-755D92B20621Q48321057-97D7401B-72B6-46B1-9F8E-BAC869B64AD7Q50106817-2BA93131-2D36-4FAC-938E-62EB274428D1Q50754280-60A01666-2FBF-4C70-A949-8E3DFA717943Q50951031-2ABFD364-8506-4A34-8607-B11F0B5E76E5Q55416268-A9DE8549-EFD7-404D-AC43-249D8F61E3AFQ57372291-0BF318CD-6B20-4A89-BCAC-434D028DC29C
P2860
Doxorubicin and paclitaxel loaded microbubbles for ultrasound triggered drug delivery.
description
2011 nî lūn-bûn
@nan
2011 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Doxorubicin and paclitaxel loaded microbubbles for ultrasound triggered drug delivery.
@ast
Doxorubicin and paclitaxel loaded microbubbles for ultrasound triggered drug delivery.
@en
type
label
Doxorubicin and paclitaxel loaded microbubbles for ultrasound triggered drug delivery.
@ast
Doxorubicin and paclitaxel loaded microbubbles for ultrasound triggered drug delivery.
@en
prefLabel
Doxorubicin and paclitaxel loaded microbubbles for ultrasound triggered drug delivery.
@ast
Doxorubicin and paclitaxel loaded microbubbles for ultrasound triggered drug delivery.
@en
P2093
P2860
P1476
Doxorubicin and paclitaxel loaded microbubbles for ultrasound triggered drug delivery.
@en
P2093
John Eisenbrey
Margaret A Wheatley
Michael C Cochran
Michael Soulen
Richard O Ouma
P2860
P304
P356
10.1016/J.IJPHARM.2011.05.030
P407
P577
2011-05-13T00:00:00Z